|
RAB12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.035600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.021000E-03 |
| Normal-vs-Stage2 |
5.546000E-02 |
| Normal-vs-Stage3 |
1.94060000002771E-06 |
| Normal-vs-Stage4 |
2.59830000004513E-06 |
| Stage1-vs-Stage2 |
6.406400E-01 |
| Stage1-vs-Stage3 |
4.659700E-03 |
| Stage1-vs-Stage4 |
2.661400E-03 |
| Stage2-vs-Stage3 |
3.514000E-01 |
| Stage2-vs-Stage4 |
3.538400E-01 |
| Stage3-vs-Stage4 |
9.822800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.014400E-04 |
| Normal-vs-AfricanAmerican |
9.244400E-03 |
| Normal-vs-Asian |
1.011380E-01 |
| Caucasian-vs-AfricanAmerican |
5.734000E-01 |
| Caucasian-vs-Asian |
7.702600E-01 |
| AfricanAmerican-vs-Asian |
5.705800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.71820000000245E-05 |
| Normal-vs-Female |
1.071530E-02 |
| Male-vs-Female |
8.817600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.781600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.739100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.41770000000796E-06 |
| Normal-vs-Age(81-100Yrs) |
4.677500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.241000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.029600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.232400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.070840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.710420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.693600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.291000E-01 |
| Normal-vs-Grade 2 |
1.136400E-01 |
| Normal-vs-Grade 3 |
4.9249000000362E-07 |
| Normal-vs-Grade 4 |
5.58119994664708E-09 |
| Grade 1-vs-Grade 2 |
2.529200E-01 |
| Grade 1-vs-Grade 3 |
5.449300E-04 |
| Grade 1-vs-Grade 4 |
1.409640E-04 |
| Grade 2-vs-Grade 3 |
1.93799999999023E-05 |
| Grade 2-vs-Grade 4 |
1.80919999981377E-07 |
| Grade 3-vs-Grade 4 |
1.910170E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.466630E-01 |
| Normal-vs-ccB subtype |
1.87870000001311E-06 |
| ccA subtype-vs-ccB subtype |
8.10260000000396E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.316750E-03 |
| Normal-vs-N1 |
2.739600E-03 |
| N0-vs-N1 |
2.064000E-01 |
|
|
